Position in AMGN
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$210,753
New position
Shares Held
582
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#2,822
of 3,140 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026WNY Asset Management, LLC holds $12,807,497 across 8 Drug Manufacturers - General names. AMGN ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,610 | $6,728,802 | |
| 2 | JNJ |
Johnson & Johnson
|
6,393 | $1,623,630 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,678 | $1,372,123 | |
| 4 | ABBV |
AbbVie Inc.
|
4,347 | $1,093,879 | |
| 5 | PFE |
Pfizer Inc
|
33,220 | $799,937 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
12,655 | $729,181 | |
| 7 | NVO |
Novo Nordisk A S
|
5,198 | $249,192 | |
| 8 | AMGN |
Amgen Inc
This page
|
582 | $210,753 |
All Filings in AMGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $210,753 | 582 | Shares | Sole | 2026-08-17 | |
| No filing history on record for this holder in this stock. | ||||||